Please login to the form below

Not currently logged in
Email:
Password:

NICE appoints Andy McKeon to Board

The National Institute for Health and Clinical Excellence has appointed Andy McKeon as a non-executive member of its Board

The National Institute for Health and Clinical Excellence (NICE) has appointed Andy McKeon as a non-executive member of its Board.

McKeon, who is managing director of health at the Audit Commission, will replace Mark Taylor who stepped down in April to take up the role of chair at an NHS Mental Health Trust.

Before joining the Audit Commission, McKeon was director of policy and planning at the Department of Health (DH) with responsibility for setting targets for the reform and improvement of health and social care policy agenda. During his time in post he was responsible for all aspects of the clinical and cost effective use of medicines in the NHS.

Mercy Jeyasingham, MBE, has been reappointed to her non-executive role on NICE's board for a further two-year term. A former member of the Ministerial Advisory Board for the Medicines Control Agency, Mercy is a management consultant and trainer who has held significant senior roles in both the public and voluntary sectors.

The appointments were made by the independent organisation the Appointments Commission which is responsible for appointing chairs and non-executive directors to NHS organisations on behalf of the Secretary of State for Health.

 

25th June 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics